Related Experiment Video
Updated: Jul 6, 2026

A Standardized Procedure for Monitoring Harmful Algal Blooms in Chile by Metabarcoding Analysis
Published on: August 26, 2021
[Burden of psychiatric diseases in Chile]
Benjamín Vicente P1, Robert Kohn, Sandra Saldivia B
1Departamento de Psiquiatría y Salud Mental, Universidad de Concepción, Concepción, Chile. bvicent@udec.cl
Insights
Chile faces a significant mental health burden, with high rates of psychiatric disorders and limited treatment access. Addressing this mental healthcare gap is crucial for public health, despite common misconceptions about treatment efficacy.
Area of Science:
- Public Health
- Psychiatry
- Global Health
Background:
- Chile experiences a high burden of neuropsychiatric disorders, impacting 31% of the population.
- Major depression and alcohol use disorders are leading causes of disability in adults.
- Anxiety disorders are the most prevalent, followed by depression and alcohol abuse.
Purpose of the Study:
- To highlight the significant mental health burden in Chile.
- To examine the challenges in mental healthcare provision and access.
- To underscore the public health implications of the mental health treatment gap.
Main Methods:
- Analysis of World Health Organization (WHO) data on disease burden.
- Review of national healthcare statistics regarding mental health budget allocation and resource availability.
- Examination of psychiatric care access and treatment utilization rates.
Main Results:
- Mental health constitutes only 2.3% of the healthcare budget, with insufficient psychiatric beds (1.3 per 10,000) and low psychiatrist density (4.0 per 100,000).
- Only 38.5% of diagnosed patients receive any mental healthcare.
- A significant perception exists that psychiatric treatments are ineffective, contradicting scientific evidence.
Conclusions:
- Chile faces a substantial mental health crisis with inadequate resources and access to care.
- The low utilization of mental health services and prevalent misconceptions about treatment efficacy exacerbate the problem.
- Urgent interventions are needed to bridge the mental health treatment gap and improve public health outcomes.
Abstract:
Chile has one of the highest disease burdens caused by neuropsychiatric illnesses in the world, according to WHO, reaching to 31%. Major depression and alcohol use disorders are ranked first and second in attributed disability among adults. Nearly one-third of the population has had a psychiatric disorder in their lifetime, and 22.2% in the past year. Anxiety disorders are the most prevalent conditions, followed by major depression and alcohol abuse. Currently, mental health accounts for 2.3%) of the health care budget, which is less than some neighboring countries. The availability of 1.3 psychiatric beds per 10,000 inhabitants, is less than the mean of lower-income countries. Moreover, 81% are for chronic rather than acute care. Chile has 4.0 psychiatrist per 100,000 inhabitants, which is lower than other countries in Latin America. Only 38.5% of those patients with a psychiatric diagnosis receive any kind of mental health care, whether from a specialist or primary care. There is a perception among lay persons, that psychiatric treatments lack efficacy, despite evidence demonstrating the contrary. Not addressing the treatment gap in mental health has serious public health implications.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
